Streamex Corp. Files 8-K: Material Agreement, Equity Sales
Ticker: STEX · Form: 8-K · Filed: Oct 29, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Streamex Corp. (STEX) |
| Form Type | 8-K |
| Filed Date | Oct 29, 2025 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $0.001, $100,000,000, $25.1 million, $12.6 million, $12.5 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financial-obligation
TL;DR
Streamex Corp. signed a new deal, sold stock, and filed financials on 10/28.
AI Summary
On October 28, 2025, Streamex Corp. entered into a material definitive agreement, creating a direct financial obligation. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. Streamex Corp. was formerly known as BioSig Technologies, Inc. until September 21, 2011.
Why It Matters
This filing indicates Streamex Corp. has entered into a significant new agreement that creates a financial obligation, and has also engaged in equity sales, which could impact its financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing details a material definitive agreement and unregistered equity sales, which can introduce financial obligations and dilution risks.
Key Players & Entities
- Streamex Corp. (company) — Registrant
- BioSig Technologies, Inc. (company) — Former company name
- October 28, 2025 (date) — Date of earliest event reported
- September 21, 2011 (date) — Date of name change from BioSig Technologies, Inc.
FAQ
What is the nature of the material definitive agreement Streamex Corp. entered into?
The filing indicates Streamex Corp. entered into a material definitive agreement on October 28, 2025, which resulted in a direct financial obligation, but the specific details of the agreement are not provided in this summary.
What type of financial obligation was created by the agreement?
The filing states that the agreement created a 'Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant', but does not specify the exact nature or amount of the obligation.
When did Streamex Corp. change its name from BioSig Technologies, Inc.?
Streamex Corp. was formerly known as BioSig Technologies, Inc. until September 21, 2011.
What information is provided regarding unregistered sales of equity securities?
The filing notes that there were 'Unregistered Sales of Equity Securities' on or around October 28, 2025, but does not provide details on the number of shares or the price.
What is the primary business of Streamex Corp. according to its SIC code?
Streamex Corp.'s Standard Industrial Classification (SIC) code is 3845, which corresponds to 'ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS'.
Filing Stats: 1,653 words · 7 min read · ~6 pages · Grade level 15 · Accepted 2025-10-29 08:00:38
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share STEX The Nasdaq Stock Mar
- $100,000,000 — an aggregate principal amount of up to $100,000,000, which Convertible Debentures will be c
- $25.1 million — other things: (i) mandate that at least $25.1 million in aggregate proceeds — $12.6 million a
- $12.6 million — t $25.1 million in aggregate proceeds — $12.6 million at the First Closing (as defined by the
- $12.5 million — y the Debenture Purchase Agreement) and $12.5 million at the Second Closing (as defined by th
- $25,000,000 — le Debenture in the principal amount of $25,000,000 (the "First Convertible Debenture"), su
- $4.00 — her date of determination, subject to a $4.00 floor price, in each case subject to ad
- $50,000,000 — an aggregate principal amount of up to $50,000,000, upon mutual agreement of the parties,
Filing Documents
- form8-k.htm (8-K) — 52KB
- ex10-1.htm (EX-10.1) — 294KB
- 0001493152-25-019993.txt ( ) — 564KB
- stex-20251028.xsd (EX-101.SCH) — 3KB
- stex-20251028_lab.xml (EX-101.LAB) — 33KB
- stex-20251028_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. Amendment to Secured Convertible Debenture Purchase Agreement and First Closing As previously disclosed in the Current Report on Form 8-K filed by Streamex Corp. (f./k/a BioSig Technologies, Inc.), a Delaware corporation (the "Company") with the Securities and Exchange Commission on July 9, 2025, and August 13, 2025 (combined together the "Prior Form 8-Ks"), the Company entered into a certain Secured Convertible Debenture Purchase Agreement, dated as of July 7, 2025 (as amended by the First Amendment and by the Second Amendment, each as defined below, the "Debenture Purchase Agreement"), with YA II PN, LTD., a Cayman Islands exempt limited company ("Yorkville" or the "Investor"), for the issuance and sale by the Company of convertible debentures (the "Convertible Debentures," each, a "Convertible Debenture") issuable in an aggregate principal amount of up to $100,000,000, which Convertible Debentures will be convertible into shares of the Company's common stock, par value $0.001 per share (the "Common Stock") (as converted, the "Conversion Shares"), as amended on August 13, 2025 by Amendment No. 1 to Secured Convertible Debenture Purchase Agreement (the "First Amendment"). Further to this, on October 28, 2025, the Company entered into a certain Amendment No. 2 to Secured Convertible Debenture Purchase Agreement (the "Second Amendment") with Yorkville. The Second Amendment further amends such Secured Convertible Debenture Purchase Agreement to, among other things: (i) mandate that at least $25.1 million in aggregate proceeds — $12.6 million at the First Closing (as defined by the Debenture Purchase Agreement) and $12.5 million at the Second Closing (as defined by the Debenture Purchase Agreement) — be deposited directly to a certain securities account for the sole purpose of purchasing Allocated Vaulted Gold Bullion (as defined in the Guaranty (as defined below), with strict compliance required under that cert
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 4.1 Form of Convertible Debenture (included in Exhibit 10.1) 10.1 Amendment No. 2 to Secured Convertible Debenture Purchase Agreement, dated as of October 28, 2025, between the Company and YA II PN, Ltd. 104 Cover Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STREAMEX CORP. Date: October 29, 2025 By: /s/ Karl Henry McPhie Name: Karl Henry McPhie Title: Chief Executive Officer